BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9369417)

  • 1. Isolation and characterization of daunorubicin-resistant AML-2 sublines.
    Choi CH; Ling V
    Mol Cells; 1997 Apr; 7(2):170-7. PubMed ID: 9163728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux.
    Nicholson R; Menezes AC; Azevedo A; Leckenby A; Davies S; Seedhouse C; Gilkes A; Knapper S; Tonks A; Darley RL
    Front Oncol; 2022; 12():840046. PubMed ID: 35707351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic modelling of the P-glycoprotein mediated efflux with a large-scale matched molecular pair analysis.
    Zhao H
    Eur J Med Chem; 2023 Dec; 261():115830. PubMed ID: 37774507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating functional and molecular impact of ex vivo sample handling in precision medicine.
    Struyf N; Österroos A; Vesterlund M; Arnroth C; James T; Sunandar S; Mermelekas G; Bohlin A; Hamberg Levedahl K; Bengtzén S; Jafari R; Orre LM; Lehtiö J; Lehmann S; Östling P; Kallioniemi O; Seashore-Ludlow B; Erkers T
    NPJ Precis Oncol; 2024 Feb; 8(1):38. PubMed ID: 38374206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
    Zeng Z; Liu W; Benton CB; Konoplev S; Lu H; Wang RY; Chen J; Shpall E; Baggerly KA; Champlin R; Konopleva M
    Acta Haematol; 2019; 142(3):176-184. PubMed ID: 31112940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features.
    Arlehamn CL; Seumois G; Gerasimova A; Huang C; Fu Z; Yue X; Sette A; Vijayanand P; Peters B
    J Immunol; 2014 Sep; 193(6):2931-40. PubMed ID: 25092889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.
    Ramesh R; Kozhaya L; McKevitt K; Djuretic IM; Carlson TJ; Quintero MA; McCauley JL; Abreu MT; Unutmaz D; Sundrud MS
    J Exp Med; 2014 Jan; 211(1):89-104. PubMed ID: 24395888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the c-kit receptor in the treatment of acute myelogenous leukemia.
    Advani AS
    Curr Hematol Malig Rep; 2006 Jun; 1(2):101-7. PubMed ID: 20425339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).
    Guzman ML; Li X; Corbett CA; Rossi RM; Bushnell T; Liesveld JL; Hébert J; Young F; Jordan CT
    Blood; 2007 Dec; 110(13):4436-44. PubMed ID: 17785584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia.
    Ustün C; Beksac M; Dalva K; Koc H; Konuk N; Ilhan O; Ozcan M; Topcuoglu P; Sertkaya D; Hayran M
    Med Oncol; 2002; 19(1):59-67. PubMed ID: 12025892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.
    Linenberger ML; Hong T; Flowers D; Sievers EL; Gooley TA; Bennett JM; Berger MS; Leopold LH; Appelbaum FR; Bernstein ID
    Blood; 2001 Aug; 98(4):988-94. PubMed ID: 11493443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
    Pallis M; Turzanski J; Higashi Y; Russell N
    Leuk Lymphoma; 2002 Jun; 43(6):1221-8. PubMed ID: 12152989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport proteins in drug resistance: detection and prognostic significance in acute myeloid leukemia.
    Broxterman HJ; Schuurhuis GJ
    J Intern Med Suppl; 1997; 740():147-51. PubMed ID: 9350197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia.
    Sincock PM; Ashman LK
    Leukemia; 1997 Nov; 11(11):1850-7. PubMed ID: 9369417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
    Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
    Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.